Opana ER (Oxymorphone)–Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C

Opana ER (Oxymorphone)–Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C

Oxymorphone is a semisynthetic extended release opiate used to treat moderate to severe chronic pain. The Food and Drug Administration approved the oral form of oxymorphone available as Opana and Opana ER (extended release) since 2006. The Food and Drug Administration and the Centers for Disease Con...

Full description

Bibliographic Details
Main Authors: Hassan Mehmood MD, Muzammil Khan MD, Asghar Marwat MD, Medha Joshi MD, Varun Malhotra MD
Format: Article
Language:English
Published: SAGE Publishing 2018-01-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/2324709618756423

Internet

https://doi.org/10.1177/2324709618756423

Similar Items